Sunday, August 30, 2026
ExploreSearch
Via News
MarketCommodities

Natural Gas Futures Went Down By Over 34% In The Last 21 Sessions

ViaNews Editorial Team

February 6, 2023

Natural Gas Futures Went Down By Over 34% In The Last 21 Sessions

(VIANEWS) - Natural Gas (NG) has been up by 34.04% for the last 21 sessions. At 07:52 EST on Monday, 6 February, Natural Gas (NG) is $2.43.

Volume

Today's last reported volume for Natural Gas is 12917, 99.99% below its average volume of 5292034213.81.

Volatility

Natural Gas's last week, last month's, and last quarter's current intraday variation average was a positive 0.89%, a negative 1.72%, and a positive 5.31%, respectively.

Natural Gas's highest amplitude of average volatility was 5.04% (last week), 4.63% (last month), and 5.31% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Natural Gas's commodity is considered to be overbought (>=80).

More news about Natural Gas (NG).

Categories

MarketCommodities

Tags

CommodityCommoditiesFuturesNGNatural GasPrice DownCommodities Price DownCommodities Now
ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Enterprise AI's Trust Gap: Microsoft-Mistral Ecosystem Expansion Meets a Governance Deficit in Agentic Adoption
Microsoft is deepening its AI platform bet through simultaneous moves — expanding its Mistral partnership (Copilot Studio, Foundry, European infrastructure capacity) and deepening enterprise AI governance ties with Manulife — just as independent research (Google Cloud, VentureBeat, Box) shows enterprises racing toward agentic AI adoption (100% planned within two years) while data access and trust in agent decisions lag badly (average 45% data access, only ~half trust agent outputs). The result is a structural mismatch between platform-vendor momentum and enterprise readiness to actually govern and trust the agents being deployed.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
Same entity (Morgan Stanley & Co. LLC), same metric (net_income), same fiscal period (Q1 2026), same observation date (2026-03-31), but vastly different values: $5.567 billion vs. $5.57. These cannot coexist for the same time period. Fact B appears to be a data entry error (possible missing decimal placement: 5.57 should likely be 5,567,000,000 or a per-share figure incorrectly entered as total).
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,257 source documents archived
Query this data → isubstrate.com